[ad_1] The global pharmaceutical industry is expected to generate $1.15 trillion in sales in 2023, according to Statista. The oncology segment alone should see $188.2 billion in sales this year.…
Tag: Gilead Sciences
Gilead cuts 7% of staff at Kite Pharma unit as ‘refreshed business strategy’ introduced
[ad_1] Gilead Sciences’ Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. In a letter sent to…
Blockbuster Cancer Treatment Stymied by Supply Chain—for Now
[ad_1] A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing. [ad_2] Source link
Higher Rates Are Coming for U.S. Companies
[ad_1] The burden of interest rates on most companies is still exceedingly low. But over the next year, that will start to change. [ad_2] Source link
Seagen’s Cancer Therapy Is Making It a Takeover Target
[ad_1] Health Novel cancer agents could shore up aging pharmaceutical portfolios for big drugmakers [ad_2] Source link
Opinion | Gilead Sciences Is the Target of a Bizarre Legal Theory
[ad_1] A lawsuit claims the biotech innovator should have rolled out a new drug sooner. [ad_2] Source link